{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:57:48Z","timestamp":1792799868709,"version":"4.5.0"},"reference-count":130,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,25]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The nexus of chronic kidney disease (CKD) and cardiovascular disease (CVD) amplifies the morbidity and mortality of CKD, emphasizing the need for defining and establishing therapeutic initiatives to modify and abrogate the progression of CKD and concomitant CV risks. In addition to the traditional CV risk factors, disturbances of mineral metabolism are specific risk factors that contribute to the excessive CV mortality in patients with CKD. These risk factors include dysregulations of circulating factors that modulate phosphate metabolism, including fibroblast growth factor 23 (FGF23) and soluble Klotho. Reduced circulating levels and suppressed renal Klotho expression may be associated with adverse outcomes in CKD patients. While elevated circulating concentrations or locally produced FGF23 in the strained heart exert prohypertrophic mechanisms on the myocardium, Klotho attenuates tissue fibrosis, progression of CKD, cardiomyopathy, endothelial dysfunction, vascular stiffness and vascular calcification. Mineralocorticoid receptor (MR) activation in nonclassical targets, mediated by aldosterone and other ligands, amplifies CVD in CKD. In concert, we detail how the interplay of elevated FGF23, activation of the MR and concomitant reductions of circulating Klotho in CKD may potentiate each other\u2019s deleterious effects on the kidney and heart, thereby contributing to the initiation and progression of kidney and cardiac functional deterioration, acting through multipronged, albeit complementary, mechanistic pathways.<\/jats:p>","DOI":"10.1093\/ndt\/gfab254","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T14:03:03Z","timestamp":1630332183000},"page":"211-221","source":"Crossref","is-referenced-by-count":14,"title":["The intersection of mineralocorticoid receptor activation and the FGF23\u2013Klotho cascade: a duopoly that promotes renal and cardiovascular injury"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7897-4812","authenticated-orcid":false,"given":"Murray","family":"Epstein","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6629-3158","authenticated-orcid":false,"given":"Michael","family":"Freundlich","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"2022030904263233800_gfab254-B1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases","volume":"96","author":"Jager","year":"2019","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrneph.2015.25","article-title":"Epidemiology: spotlight on CKD deaths\u2014increasing mortality worldwide","volume":"11","author":"Rhee","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"2022030904263233800_gfab254-B3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","journal-title":"Lancet"},{"key":"2022030904263233800_gfab254-B4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"2022030904263233800_gfab254-B5","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1681\/ASN.2020111583","article-title":"Primary nephrotic syndrome and risks of end-stage kidney disease, cardiovascular events, and death: the Kaiser Permanente Nephrotic Syndrome Study","volume":"32","author":"Go","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B6","volume-title":"2019 USRDS Annual Data Report: Epidemiology of kidney disease in the United States.","author":"United States Renal Data System","year":"2019"},{"key":"2022030904263233800_gfab254-B7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2215\/CJN.07070619","article-title":"Survival after kidney transplantation during childhood and adolescence","volume":"15","author":"Francis","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrneph.2012.33","article-title":"Statins in the management of dyslipidemia associated with chronic kidney disease","volume":"8","author":"Epstein","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"2022030904263233800_gfab254-B9","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1007\/s00467-020-04843-6","article-title":"Fibroblast growth factor 23\u2013Klotho and hypertension: experimental and clinical mechanisms","author":"Freundlich","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"2022030904263233800_gfab254-B10","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.2215\/CJN.02640310","article-title":"Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the \"trade-off\" hypothesis","volume":"5","author":"Guti\u00e9rrez","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B11","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"2022030904263233800_gfab254-B12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajh\/hpy154","article-title":"Cardioprotective effects of paricalcitol alone and in combination with FGF23 receptor inhibition in chronic renal failure: experimental and clinical studies","volume":"32","author":"Czaya","year":"2019","journal-title":"Am J Hypertens"},{"key":"2022030904263233800_gfab254-B13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00467-016-3505-3","article-title":"Extrarenal effects of FGF23","volume":"32","author":"Haffner","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"2022030904263233800_gfab254-B14","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1681\/ASN.2020010081","article-title":"A land of controversy: fibroblast growth factor-23 and uremic cardiac hypertrophy","volume":"31","author":"Bao","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B15","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00467-012-2224-7","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis","volume":"27","author":"Seeherunvong","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"2022030904263233800_gfab254-B16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.10331011","article-title":"FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy","volume":"7","author":"Lundberg","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jash.2017.04.001","article-title":"Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males","volume":"11","author":"Falkner","year":"2017","journal-title":"J Am Soc Hypertens"},{"key":"2022030904263233800_gfab254-B18","doi-asserted-by":"crossref","first-page":"H2283","DOI":"10.1152\/ajpheart.00798.2020","article-title":"Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner","volume":"320","author":"Graves","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022030904263233800_gfab254-B19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.kint.2018.02.017","article-title":"The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk","volume":"94","author":"Pastor-Arroyo","year":"2018","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol Med"},{"key":"2022030904263233800_gfab254-B21","doi-asserted-by":"crossref","first-page":"p31","DOI":"10.1159\/000314542","article-title":"Changes in the sodium and potassium transporters in the course of chronic renal failure","volume":"115","author":"Kim","year":"2010","journal-title":"Nephron Physiol"},{"key":"2022030904263233800_gfab254-B22","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1681\/ASN.2014010104","article-title":"Proteinuria increases plasma phosphate by altering its tubular handling","volume":"26","author":"de Seigneux","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000343393","article-title":"Enhanced FGF23 serum concentrations and phosphaturia in gene targeted mice expressing WNK-resistant SPAK","volume":"36","author":"Pathare","year":"2012","journal-title":"Kidney Blood Press Res"},{"key":"2022030904263233800_gfab254-B24","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1038\/s41598-018-22041-1","article-title":"Elevated FGF23 levels in mice lacking the thiazide-sensitive NaCl cotransporter (NCC)","volume":"8","author":"Pathare","year":"2018","journal-title":"Sci Rep"},{"key":"2022030904263233800_gfab254-B25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbrc.2016.01.034","article-title":"Up-regulation of FGF23 release by aldosterone","volume":"470","author":"Zhang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"2022030904263233800_gfab254-B26","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/ndt\/gfy315","article-title":"Fibroblast growth factor 23 is associated with fractional excretion of sodium in patients with chronic kidney disease","volume":"34","author":"Xu","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B27","first-page":"389","article-title":"Fibroblast growth factor 23 and tubular sodium handling in young patients with incipient chronic kidney disease","volume":"13","author":"Freundlich","year":"2020","journal-title":"Clin Kidney J"},{"key":"2022030904263233800_gfab254-B28","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1\u03b1,25-dihydroxyvitamin D3 and phosphorus in vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J Biol Chem"},{"key":"2022030904263233800_gfab254-B29","doi-asserted-by":"crossref","first-page":"F1088","DOI":"10.1152\/ajprenal.00474.2004","article-title":"Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism","volume":"289","author":"Shimada","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022030904263233800_gfab254-B30","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00467-016-3356-y","article-title":"Fibroblast growth factor-23 and renin-angiotensin system levels in vitamin-D-dependent rickets type I","volume":"31","author":"Cuervo","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"2022030904263233800_gfab254-B31","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1074\/jbc.M113.500850","article-title":"Sympathetic activation induces skeletal FGF23 expression in a circadian rhythm-dependent manner","volume":"289","author":"Kawai","year":"2014","journal-title":"J Biol Chem"},{"key":"2022030904263233800_gfab254-B32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.semnephrol.2014.09.005","article-title":"New insights into the FGF23-klotho axis","volume":"34","author":"Olauson","year":"2014","journal-title":"Semin Nephrol"},{"key":"2022030904263233800_gfab254-B33","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/ndt\/gfy189","article-title":"Effects of erythropoietin on fibroblast growth factor 23 in mice and humans","volume":"34","author":"Hanudel","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bone.2016.09.010","article-title":"FGF23-klotho signaling axis in the kidney","volume":"100","author":"Erben","year":"2017","journal-title":"Bone"},{"key":"2022030904263233800_gfab254-B35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ndt\/gfy126","article-title":"Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?","volume":"34","author":"Kuro-O","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B36","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1006\/bbrc.1997.8019","article-title":"Identification of the human klotho ene and its two transcripts encoding membrane and secreted klotho protein","volume":"242","author":"Matsumura","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2022030904263233800_gfab254-B37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2017.03.043","article-title":"Tissue expression and source of circulating \u03b1Klotho","volume":"100","author":"Olauson","year":"2017","journal-title":"Bone"},{"key":"2022030904263233800_gfab254-B38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000452880","article-title":"Klotho\/FGF23 axis in chronic kidney disease and cardiovascular disease","volume":"3","author":"Lu","year":"2017","journal-title":"Kidney Dis (Basel)"},{"key":"2022030904263233800_gfab254-B39","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1096\/fj.10-154765","article-title":"Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule","volume":"24","author":"Hu","year":"2010","journal-title":"FASEB J"},{"key":"2022030904263233800_gfab254-B40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbrc.2011.09.117","article-title":"Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells","volume":"414","author":"Forster","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"2022030904263233800_gfab254-B41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1210\/er.2013-1079","article-title":"Molecular basis of Klotho: from gene to function in aging","volume":"36","author":"Xu","year":"2015","journal-title":"Endocr Rev"},{"key":"2022030904263233800_gfab254-B42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/toxins12030185","article-title":"Klotho\/FGF23 and Wnt signaling as important players in the comorbidities associated with chronic kidney disease","volume":"12","author":"Mu\u00f1oz-Casta\u00f1eda","year":"2020","journal-title":"Toxins (Basel)"},{"key":"2022030904263233800_gfab254-B43","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/ndt\/gfs160","article-title":"The emerging role of Klotho in clinical nephrology","volume":"27","author":"Hu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B44","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1073\/pnas.1620301114","article-title":"Soluble klotho binds monosialoganglioside to regulate membrane microdomains and growth factor signaling","volume":"114","author":"Dalton","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022030904263233800_gfab254-B45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2016.05.008","article-title":"Update on FGF23 and Klotho signaling","volume":"432","author":"Erben","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"2022030904263233800_gfab254-B46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature25451","article-title":"\u03b1Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling","volume":"553","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"2022030904263233800_gfab254-B47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/ckj\/sfu074","article-title":"Longitudinal FGF23 and klotho axis characterization in children treated with chronic peritoneal dialysis","volume":"7","author":"Cano","year":"2014","journal-title":"Clin Kidney J"},{"key":"2022030904263233800_gfab254-B48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ndt\/gfs460","article-title":"Secreted Klotho and FGF23 in chronic kidney disease stage 1 to 5: a sequence suggested from a cross-sectional study","volume":"28","author":"Pavik","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.semnephrol.2012.12.013","article-title":"Renal and extrarenal actions of Klotho","volume":"33","author":"Hu","year":"2013","journal-title":"Semin Nephrol"},{"key":"2022030904263233800_gfab254-B50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1681\/ASN.2014101030","article-title":"Renal production, uptake, and handling of circulating \u03b1Klotho","volume":"27","author":"Hu","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ndt\/gfu291","article-title":"The demonstration of \u03b1Klotho deficiency in human chronic kidney disease with a novel synthetic antibody","volume":"30","author":"Barker","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ki.2012.288","article-title":"Plasma klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease","volume":"83","author":"Seiler","year":"2013","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ckj\/sfz085","article-title":"Performance of soluble Klotho assays in clinical samples of kidney disease","volume":"13","author":"Neyra","year":"2020","journal-title":"Clin Kidney J"},{"key":"2022030904263233800_gfab254-B54","first-page":"643","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Sci Rep"},{"key":"2022030904263233800_gfab254-B55","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/s41598-017-01882-2","article-title":"Involvement of vascular aldosterone synthase in phosphate-induced osteogenic transformation of vascular smooth muscle cells","volume":"7","author":"Alesutan","year":"2017","journal-title":"Sci Rep"},{"key":"2022030904263233800_gfab254-B56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fendo.2018.00207","article-title":"Therapeutic interference with vascular calcification-lessons from klotho-hypomorphic mice and beyond","volume":"9","author":"Lang","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022030904263233800_gfab254-B57","doi-asserted-by":"crossref","first-page":"F967","DOI":"10.1152\/ajprenal.00669.2014","article-title":"Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification","volume":"309","author":"Tatsumoto","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022030904263233800_gfab254-B58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.2009060640","article-title":"Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification","volume":"21","author":"Shroff","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B59","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1681\/ASN.2014040325","article-title":"Soluble klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate","volume":"26","author":"Xie","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B60","doi-asserted-by":"crossref","first-page":"e56695","DOI":"10.1371\/journal.pone.0056695","article-title":"A decreased level of serum soluble klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease","volume":"8","author":"Kitagawa","year":"2013","journal-title":"PLoS One"},{"key":"2022030904263233800_gfab254-B61","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41390-020-0803-z","article-title":"Effects of Klotho supplementation on hyperoxia-induced renal injury in a rodent model of postnatal nephrogenesis","volume":"88","author":"Ali","year":"2020","journal-title":"Pediatr Res"},{"key":"2022030904263233800_gfab254-B62","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.1038\/s41598-020-69296-1","article-title":"Soluble Klotho, a biomarker and therapeutic strategy to reduce bronchopulmonary dysplasia and pulmonary hypertension in preterm infants","volume":"10","author":"Batlahally","year":"2020","journal-title":"Sci Rep"},{"key":"2022030904263233800_gfab254-B63","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.1998.8943","article-title":"Klotho protein protects against endothelial dysfunction","volume":"248","author":"Saito","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2022030904263233800_gfab254-B64","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/HYPERTENSIONAHA.115.06033","article-title":"Haplodeficiency of klotho gene causes arterial stiffening via upregulation of scleraxis expression and induction of autophagy","volume":"66","author":"Chen","year":"2015","journal-title":"Hypertension"},{"key":"2022030904263233800_gfab254-B65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1681\/ASN.2013101033","article-title":"Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1\/CC chemokine receptor 2-mediated inflammation","volume":"26","author":"Zhou","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B66","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2215\/CJN.07870713","article-title":"Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2\u20134","volume":"9","author":"Seiler","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B67","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1007\/s00467-021-05102-y","article-title":"Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation","volume":"36","author":"Shroff","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"2022030904263233800_gfab254-B68","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1681\/ASN.2014090947","article-title":"Normal 25-hydroxyvitamin D levels in children with CKD","volume":"27","author":"Shroff","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B69","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12020-009-9181-3","article-title":"Klotho suppresses TNF-\u03b1-induced expression of adhesion molecules in the endothelium and attenuates NF-\u03baB activation","volume":"35","author":"Maekawa","year":"2009","journal-title":"Endocrine"},{"key":"2022030904263233800_gfab254-B70","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ki.2012.322","article-title":"Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet","volume":"82","author":"Lau","year":"2012","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B71","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/ndt\/gfy006","article-title":"Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts","volume":"33","author":"Leifheit-Nestler","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B72","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.M705495200","article-title":"1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter","volume":"282","author":"Yuan","year":"2007","journal-title":"J Biol Chem"},{"key":"2022030904263233800_gfab254-B73","doi-asserted-by":"crossref","first-page":"12398","DOI":"10.1038\/s41598-018-30098-1","article-title":"Cardiovascular interactions between fibroblast growth factor-23 and angiotensin II","volume":"8","author":"Pi","year":"2018","journal-title":"Sci Rep"},{"key":"2022030904263233800_gfab254-B74","doi-asserted-by":"crossref","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","article-title":"A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model","volume":"7","author":"Dai","year":"2012","journal-title":"PLoS One"},{"key":"2022030904263233800_gfab254-B75","doi-asserted-by":"crossref","first-page":"F1168","DOI":"10.1152\/ajprenal.00606.2015","article-title":"FGF23 from bench to bedside","volume":"310","author":"Kovesdy","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022030904263233800_gfab254-B76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/HYPERTENSIONAHA.116.07088","article-title":"Angiotensin 1-7 is a negative modulator of aldosterone secretion in vitro and in vivo","volume":"68","author":"Shefer","year":"2016","journal-title":"Hypertension"},{"key":"2022030904263233800_gfab254-B77","first-page":"73","article-title":"Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis","volume":"32","author":"de Jong","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B78","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1253\/circj.72.1346","article-title":"Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes","volume":"72","author":"Yamamuro","year":"2008","journal-title":"Circ J"},{"key":"2022030904263233800_gfab254-B79","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","article-title":"Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease","volume":"31","author":"Leifheit-Nestler","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B80","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2003-030373","article-title":"Aldosterone: direct effects on and production by the heart","volume":"88","author":"White","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2022030904263233800_gfab254-B81","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.408","article-title":"Suppression of renin-angiotensin gene expression in the kidney by paricalcitol","volume":"74","author":"Freundlich","year":"2008","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B82","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/ajh\/hpt177","article-title":"Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats","volume":"27","author":"Freundlich","year":"2014","journal-title":"Am J Hypertens"},{"key":"2022030904263233800_gfab254-B83","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2022030904263233800_gfab254-B84","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ndt\/gfm672","article-title":"Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23","volume":"23","author":"Marsell","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B85","doi-asserted-by":"crossref","first-page":"F534","DOI":"10.1152\/ajprenal.00082.2015","article-title":"Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria","volume":"310","author":"Riera","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022030904263233800_gfab254-B86","author":"World Health Organization"},{"key":"2022030904263233800_gfab254-B87","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction, and cardiac fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation"},{"key":"2022030904263233800_gfab254-B88","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/HYPERTENSIONAHA.115.06642","article-title":"Leptin induces hypertension and endothelial dysfunction via aldosterone-dependent mechanisms in obese female mice","volume":"67","author":"Huby","year":"2016","journal-title":"Hypertension"},{"key":"2022030904263233800_gfab254-B89","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000237742","article-title":"Predictors of hyperkalemia risk following hypertension control with aldosterone blockade","volume":"30","author":"Khosla","year":"2009","journal-title":"Am J Nephrol"},{"key":"2022030904263233800_gfab254-B90","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jbmr.65","article-title":"Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1\u03b1,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice","volume":"25","author":"Tsuji","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2022030904263233800_gfab254-B91","first-page":"1803","article-title":"Aldosterone induces renal fibrosis by promoting HDAC1 expression, deacetylating H3K9 and inhibiting klotho transcription","volume":"19","author":"Lai","year":"2019","journal-title":"Mol Med Rep"},{"key":"2022030904263233800_gfab254-B92","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/ndt\/gfq537","article-title":"Angiotensin II blockade upregulates the expression of klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy","volume":"26","author":"Yoon","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B93","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1681\/ASN.2015010093","article-title":"Antiaging gene klotho regulates adrenal CYP11B2 expression and aldosterone synthesis","volume":"27","author":"Zhou","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B94","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1016\/j.ajpath.2015.08.004","article-title":"Klotho ameliorates kidney injury and fibrosis and normalizes blood pressure by targeting the renin-angiotensin system","volume":"185","author":"Zhou","year":"2015","journal-title":"Am J Pathol"},{"key":"2022030904263233800_gfab254-B95","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ Res"},{"key":"2022030904263233800_gfab254-B96","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/26.7.671","article-title":"Reactive and reparative myocardial fibrosis in arterial hypertension in the rat","volume":"26","author":"Brilla","year":"1992","journal-title":"Cardiovasc Res"},{"key":"2022030904263233800_gfab254-B97","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.mce.2011.06.038","article-title":"Aldosterone, mineralocorticoid receptor, and heart failure","volume":"350","author":"Messaoudi","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2022030904263233800_gfab254-B98","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/pr.115.011106","article-title":"Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology","volume":"68","author":"Jaisser","year":"2016","journal-title":"Pharmacol Rev"},{"key":"2022030904263233800_gfab254-B99","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ki.2011.48","article-title":"Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease","volume":"79","author":"Bertocchio","year":"2011","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"key":"2022030904263233800_gfab254-B101","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ Res"},{"key":"2022030904263233800_gfab254-B102","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/21541248.2016.1211398","article-title":"Rac1 in human diseases: the therapeutic potential of targeting Rac1 signaling regulatory mechanisms","volume":"8","author":"Marei","year":"2017","journal-title":"Small GTPases"},{"key":"2022030904263233800_gfab254-B103","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nrneph.2012.282","article-title":"Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease","volume":"9","author":"Nagase","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"2022030904263233800_gfab254-B104","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1172\/JCI43124","article-title":"Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway","volume":"121","author":"Shibata","year":"2011","journal-title":"J Clin Invest"},{"key":"2022030904263233800_gfab254-B105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1681\/ASN.2020071041","article-title":"The mineralocorticoid receptor in salt-sensitive hypertension and renal injury","volume":"32","author":"Ayuzawa","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263233800_gfab254-B106","doi-asserted-by":"crossref","first-page":"9797","DOI":"10.1096\/fj.201802489RR","article-title":"Rac-GTPase promotes fibrotic TGF-\u03b21 signaling and chronic kidney disease via EGFR, p53, and Hippo\/YAP\/TAZ pathways","volume":"33","author":"Patel","year":"2019","journal-title":"FASEB J"},{"key":"2022030904263233800_gfab254-B107","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.kint.2017.03.010","article-title":"Rac1 activation in podocytes induces the spectrum of nephrotic syndrome","volume":"92","author":"Robins","year":"2017","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B108","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.20105.1","article-title":"Podocyte RhoGTPases: new therapeutic targets for nephrotic syndrome?","volume":"8","author":"Saleem","year":"2019","journal-title":"F1000Res"},{"key":"2022030904263233800_gfab254-B109","author":"Dagon","journal-title":"Kidney Week 2020: Abstract PO1965"},{"key":"2022030904263233800_gfab254-B110","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/1873-3468.12096","article-title":"Fibroblast growth factor (Fgf) 23 gene transcription depends on actin cytoskeleton reorganization","volume":"590","author":"Fajol","year":"2016","journal-title":"FEBS Lett"},{"key":"2022030904263233800_gfab254-B111","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"2022030904263233800_gfab254-B112","doi-asserted-by":"crossref","first-page":"e0128655","DOI":"10.1371\/journal.pone.0128655","article-title":"1,25 Dihydroxyvitamin D3 inhibits TGF\u03b21-mediated primary human cardiac myofibroblast activation","volume":"10","author":"Meredith","year":"2015","journal-title":"PLoS One"},{"key":"2022030904263233800_gfab254-B113","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/ndt\/gfaa373","article-title":"Effects of calcitriol and paricalcitol on renal fibrosis in CKD","volume":"36","author":"Mart\u00ednez-Arias","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2022030904263233800_gfab254-B114","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"2022030904263233800_gfab254-B115","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/intimm\/dxy054","article-title":"Macrophages in inflammation, repair and regeneration","volume":"30","author":"Oishi","year":"2018","journal-title":"Int Immunol"},{"key":"2022030904263233800_gfab254-B116","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41581-019-0158-z","article-title":"The role of inflammasomes in kidney disease","volume":"15","author":"Komada","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2022030904263233800_gfab254-B117","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.2014.271","article-title":"Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy","volume":"87","author":"Shahzad","year":"2015","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B118","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000368940","article-title":"Update on inflammation in chronic kidney disease","volume":"39","author":"Akchurin","year":"2015","journal-title":"Blood Purif"},{"key":"2022030904263233800_gfab254-B119","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.3390\/ijms20174195","article-title":"The role of fibroblast growth factor 23 in inflammation and anemia","volume":"20","author":"Czaya","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2022030904263233800_gfab254-B120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B121","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.kint.2018.02.026","article-title":"Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease","volume":"94","author":"Durlacher-Betzer","year":"2018","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B122","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B123","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease","volume":"14","author":"Shibata","year":"2008","journal-title":"Nat Med"},{"key":"2022030904263233800_gfab254-B124","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(01)80115-3","article-title":"Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications","volume":"37","author":"Epstein","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2022030904263233800_gfab254-B125","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ki.2011.505","article-title":"Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms","volume":"81","author":"Shavit","year":"2012","journal-title":"Kidney Int"},{"key":"2022030904263233800_gfab254-B126","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/164_2016_76","article-title":"Steroidal and novel non-steroidal mineralocorticoid receptor antagonists in heart failure and cardiorenal diseases: comparison at bench and bedside","volume":"243","author":"Kolkhof","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"2022030904263233800_gfab254-B127","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S2213-8587(15)00289-2","article-title":"Reduction of cardiovascular risk in chronic kidney disease by mineralocorticoid receptor antagonism","volume":"3","author":"Epstein","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022030904263233800_gfab254-B128","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-8587(14)70216-5","article-title":"Mineralocorticoid receptor antagonists: part of an emerging treatment paradigm for chronic kidney disease","volume":"2","author":"Epstein","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022030904263233800_gfab254-B129","first-page":"CD013109","article-title":"Aldosterone antagonists for people with chronic kidney disease requiring dialysis","volume":"2","author":"Hasegawa","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2022030904263233800_gfab254-B130","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfab254\/40809261\/gfab254.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/2\/211\/42771833\/gfab254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/2\/211\/42771833\/gfab254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T08:26:40Z","timestamp":1673166400000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/37\/2\/211\/6359827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":130,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,8,30]]},"published-print":{"date-parts":[[2022,1,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfab254","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2]]},"published":{"date-parts":[[2021,8,30]]}}}